29.03.2023 • News

Air Liquide Builds Pilot Ammonia Cracking Plant

Air Liquide plans to build an ammonia cracking pilot plant in the Port of Antwerp, Belgium. The plant will be based on a novel process using Air Liquide’s proprietary technologies and is scheduled to start operating in 2024.

Ammonia can be used an energy carrier for hydrogen The cracking process splits ammonia into its constituent parts - hydrogen and nitrogen — making it an ideal carrier for transporting hydrogen over long distances. When produced with renewable energy sources, the ammonia (and hydrogen) has a low-carbon footprint, contributing to decarbonization efforts. 

Executive vice president Michael Graff said: “Ammonia cracking complements Air Liquide’s already thorough portfolio of hydrogen technologies and adds yet another technological solution to enable the development of a hydrogen global market. More than ever, the group is committed to making hydrogen a key element of the fight against climate change, in particular for the decarbonization of heavy industry and mobility.”

© Air Liquide
© Air Liquide

The Flemish Agency for Innovation and Entrepreneurship (VLAIO) has confirmed it will provide financial support to the project.

Air Liquide has previously stated its aim to at least triple its hydrogen revenues to more than €6 billion by 2035, by when it also plans to invest about €8 billion in the renewable and low-carbon hydrogen supply chain.

Earlier this month, Saudi Aramco and Linde Engineering announced plans to jointly develop new ammonia cracking technology and build a demonstration plant in northern Germany.

Author: Elaine Burridge, Freelance Journalist

Virtual Event

High Performance Food Production
Perfection Starts in the Tank

High Performance Food Production

March 24, 2026 | Optimize your food production with smarter mixing—join the Ystral seminar to discover 20 real-world applications that cut processing times, reduce costs, and boost product quality.

Expert Insights

ADCs for Precision Cancer Therapy
Comprehensive Insights into Antibody–Drug Conjugates

ADCs for Precision Cancer Therapy

Explore how antibody-drug conjugates are reshaping precision cancer therapy and discover what it takes to successfully develop, manufacture, and scale these complex biologics.

most read

Photo

VCI Welcomes US-EU Customs Deal

The German Chemical Industry Association (VCI) welcomes the fact that Ursula von der Leyen, President of the European Commission, and US President Donald Trump have averted the danger of a trade war for the time being.